Kezar Life Sciences, Inc. (KZR) Q2 2024 Earnings
KZR·Reported August 13, 2024·Before market open
Diluted EPS came in at $-2.80, beat the $-3.20 consensus by $0.40.
Diluted EPS
$-2.80beat by $0.40
Consensus: $-3.20
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Kezar Life Sciences, Inc.'s Q2 2024 earnings report.
Kezar Life Sciences, Inc. (KZR) reported Q2 2024 earnings on August 13, 2024 before market open.
Kezar Life Sciences, Inc. reported diluted EPS of $-2.80 for Q2 2024.
EPS beat the consensus estimate of $-3.20 by $0.40.
You can read the 10-Q periodic report (0000950170-24-096213) directly on SEC EDGAR. The filing index links above go to sec.gov.